Model parameters | OptionB | OptionB+ |
---|---|---|
US$/Infection averted | ||
Cost of ART(US$) | ||
including the lifetime ART cost of infant(69.5 years) | 1608.37 | 1557.29 |
efficacy of Option B/Option B+ in reducing transmission rates | ||
Best case-1.00% | 1207.50 | 1155.23 |
Worst case-5.00% | 1209.57 | 1157.22 |
US$/QALY aquired | ||
Cost of ART(US$) | ||
including the lifetime ART cost of infant(69.5 years) | 27.81 | 26.93 |
efficacy of Option B/Option B+ in reducing transmission rates | ||
Best case-1.00% | 20.89 | 19.98 |
Worst case-5.00% | 20.92 | 20.01 |